Famciclovir for recurrent herpes-associated erythema multiforme: A series of three cases  by Routt, Ethan & Levitt, Jacob
Table I. Summary of patients with postoperative
pyoderma gangrenosum
Variable No. (%)
Total patients 87
Prior pyoderma gangrenosum (PG) 19 (21)
Postoperative 12
Spontaneous 5
Traumatic 2
Prior surgeries without PG 14 (16)
Days to onset after surgery
Average 7
Range 1-21
Procedures after postoperative PG 19 (21)
Skin grafts 14
Recurrence of PG 0
Other* 5
Recurrence of PG 4
*Other procedures include femoral bypass, breast reconstruction,
total hip repair, flap procedure/skin graft for postsurgical PG of the
knee, flap procedure to cover for breast implants.
Fig 1. Pyoderma gangrenosum. Surgical locations asso-
ciated with postoperative PG.
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e146 LettersNineteen (21%) cases had a subsequent surgical
procedure after initial PPG: 14 skin grafts, 1 femoral
bypass, 1 breast reconstruction, 1 breast flap proce-
dure, 1 flap procedure for postsurgical PGof the knee,
and 1 total hip repair. PPG did not develop after any
skin grafting procedures (14 of 19 cases) postopera-
tively at either the donor or grafted sites. In contrast, 4
of 5 noneskin graft procedures developed PPG.
Our review indicates a higher propensity of PPG
following chest wall surgery. Recognizing pathergy
as a potential trigger of PPG, we speculate the chest
wall predominance of PPG could be related to
increased mechanical stress on wounds in this
region, similar to the propensity of keloids to occur
on the chest. Our review also noted lower recur-
rence of PPG in skin graft procedures than in other
procedures, although the numbers were small. The
less invasive nature of skin graft harvesting andOpen access under CC BY-NC-ND license.placement, compared with more invasive initial
surgical procedures, may explain why PG did not
occur postoperatively in these cases. Concomitant
use of immunosuppressants during skin grafting
may have also contributed to lack of PPG seen
following skin grafting. Further studies are needed
in this area, because dermatologists are often asked
to comment on the probability of PG recurrence
with subsequent surgeries.
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Famciclovir for recurrent herpes-associated
erythema multiforme: A series of three cases
To the Editor: Patient 1 is a 50-year-old Caucasian
woman with serologically proven herpes simplex
virus (HSV) 2 (negative for HSV 1) who presented
in September 2012 with herpes-associated ery-
thema multiforme (HAEM) of 15 years’ duration.
Mycophenolate mofetil, cyclosporine, methotrexate,
adalimumab, intravenous immunoglobulin (IVIg),
valacyclovir, acyclovir, doxycycline, hydroxychloro-
quine, oxycodone, hydroxyzine, and long-term
prednisone (which induced osteoporosis) were tried
by multiple academic dermatologists but were
unsuccessful. Examination revealed red, targetoid,
confluent plaques, some eroded, on her face, trunk,
and extremities without mucosal involvement.
Serology was positive for Mycoplasma pneumoniae
IgG. The patient partially responded to methyl-
prednisolone 125 mg intravenously followed by
prednisone 60 mg. Biopsy confirmed HAEM.
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after famciclovir 500 mg was given 3 times daily.1
The patient remains clear at 19 months on oral
famciclovir 500 mg daily.
Patient 2 is a 65-year-old Caucasian woman who
was seen 1 year earlier by a dermatologist for
erythematous targetoid lesions on her right lower
extremity, which was treated with doxycycline
100 mg twice daily for 2 weeks without effect.
Lyme titer was negative. She presented in July 2013
with an erythematous targetoid macule of her
left calf with a central bulla of 5 days’ duration.
Biopsy showed erythema multiforme. Five weeks
of valacyclovir 1 g daily and desoximetasone
0.25% ointment twice daily failed. Confirmatory
HSV 1 and 2 and M. pneumoniae titers were
positive. Since switching to famciclovir 500 mg
daily, the patient has been free of HAEM lesions
for 7 months.
Patient 3 is a 27-year-old Latina woman with
serologically proven HSV 1 and 2 who presented
several years ago to a dermatologist with targetoid
macules and bullae of her hands and elbows
and erosions of her hard palate. After valacyclovir
treatment failed, she saw a rheumatologist, who
diagnosed pemphigus vulgaris, reportedly by biopsy
(no anti-desmoglein titers were drawn), and initiated
prednisone at varying doses as high as 80 mg, a
regimen she has been on since. Her course waxed
and waned, prompting a trial of IVIg and rituximab,
which resulted in 5 months of improvement.
Ultimately, her lesions recurred. On presentation to
us in February 2014, she was Cushingoid with
erythematous targetoid lesions with central bullae
on her fingers and erosions on her hard palate.
Biopsy and positive titers of HSV 1 and 2 confirmed
HAEM. Bone densitometry predictably revealed
osteopenia. Following treatment with famciclovir
500 mg orally twice daily, her palatal and cutaneous
erosions resolved completely. Upon prednisone
taper, some lesions recurred, prompting increase of
famciclovir to 3 times daily. At 75 days since
beginning treatment, she is stable on this dose and
off prednisone.
Our patients failed valacyclovir, then multiple
immunosuppressive medications, yet responded
dramatically to famciclovir. Patients 1 and 3 suffered
significant morbidity from long-term corticosteroid
therapy and were exposed fruitlessly to numerous
immunosuppressive medications. We have found
famciclovir 500 mg orally 2 to 3 times daily to be
effective initial treatment for refractory cases of
HAEM with maintenance therapy at 500 mg daily. A
failed trial of valacyclovir should not preclude a trial
of famciclovir. All safe antiviral medications shouldbe trialed in cases of chronic HAEM before moving to
long-term immunosuppressive therapy.
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Acute generalized exanthematous pustulosis
associated with 2 common medications:
Hydroxyzine and benzocaine
To the Editor: Acute generalized exanthematous
pustulosis (AGEP) is a significant adverse cutaneous
reaction most often induced by drugs or acute
infections. In drug-induced AGEP, determining the
responsible medication is important, as is identifying
cross-reactants, in that early discontinuation and
future avoidance of these agents help reduce
morbidity.
The clinical hallmark of AGEP is the sudden onset
of multiple, disseminated, nonfollicular, sterile pus-
tules on an erythematous background, usually with
intertriginous accentuation associated with fever
(temperature greater than 388C) and neutrophilia
([73 109⁄ L). AGEP generally resolves 2 weeks after
the causative drug is withdrawn.
In our first case, AGEP induced by benzocaine,
a 67-year-old man presented with a severe, wide-
spread, pustular eruption with associated fevers,
rigors, watery diarrhea, and malaise. Twenty-four
hours before the drug eruption, the patient had
dental extraction and received a benzocaine spray.
Examination demonstrated confluent erythema
studded with nonfollicular pustules distributed on
the face, trunk, and extremities. Biopsies demon-
strated histologic features consistent with AGEP.
The patient was treated with oral prednisone and
topical corticosteroids. After a 3-day hospitalization,
he clinically improved and was discharged home.
